Related Experiment Video
Updated: Aug 17, 2026
MALDI-ToF MS Method for the Characterization of Synthetic Polymers with Varying Dispersity and End Groups
Published on: October 3, 2025
221st ACS. Division of Medicinal Chemistry - company focus
1Current Drugs Ltd, Middlesex House, 34-42 Cleveland Street, London, W1T 4LB, UK. peter.robins@current-drugs.com
Idrugs : the Investigational Drugs Journal
|July 8, 2005
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Kelp detritus: Unutilized productivity or an unacknowledged trophic resource?
The Science of the total environment·2022
Impact of peer support on inpatient and outpatient payments among people with Type 2 diabetes: a prospective cohort study.
Diabetic medicine : a journal of the British Diabetic Association·2018
SMi'S 4th Annual Orphan Drugs and Rare Diseases Conference (October 19-20, 2015--London, UK).
Drugs of today (Barcelona, Spain : 1998)·2015
Anticoagulation strategies.
IDrugs : the investigational drugs journal·2008
Protein farnesyltransferase and adenosine receptors.
IDrugs : the investigational drugs journal·2008
Mitigation assessment of vegetated drainage ditches for collecting irrigation runoff in California.
Journal of environmental quality·2008
Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection.
IDrugs : the investigational drugs journal·2010
Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.
IDrugs : the investigational drugs journal·2010
LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome.
IDrugs : the investigational drugs journal·2010
Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.
IDrugs : the investigational drugs journal·2010
Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety.
IDrugs : the investigational drugs journal·2010
Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease.
IDrugs : the investigational drugs journal·2010
In Vitro and Clinical Dermatological Effects of Rubus crataegifolius Fruit Extracts on Human Fibroblasts and Keratinocytes.
Pharmaceuticals (Basel, Switzerland)·2026
Effects of Chronic Banisteriopsis caapi Extract Administration on Fibrillar Amyloid Deposition and Microglial Morphology in Aged PDGFB-APPSwInd Mice.
Pharmaceuticals (Basel, Switzerland)·2026